A Danbury woman says she has been unable to get hydroxychloroquine, the drug she needs due to an immune disorder, because the FDA approved it as a possible coronavirus treatment.

Petra Carraro says without the medication, her immune system will destroy her organs. She says she's nervous because hydroxychloroquine has been vanishing from pharmacists' shelves.

President Donald Trump recently pushed hydroxychloroquine as a possible COVID-19 treatment, in spite of very few clinical trials to back it up.

The FDA approved the drug for widespread coronavirus treatment Monday. The move may help Carraro because the pharmaceutical industry is donating 30 million doses of hydroxychloroquine to increase supply.

Carraro's doctor says the move is risky because she only has a two-week supply left of the drug she needs.

Associate clinical professor Thomas Buckley, who works at the University of Connecticut School of Pharmacy, says that the owner of Stolls Pharmacy in Waterbury has been limiting who gets the medication to to just patients who have approved conditions.

Buckley says even with the restrictions, Stolls Pharmacy will be out of hydroxychloroquine by the end of April.

"At this point, patients on these medications should be discussing with their physicians if there are any alternative options they could prescribe well before they run out of the medication," says Buckley.

Trump says 1,100 coronavirus patients in New York are currently receiving the two drugs. He believes doctors will have a "good idea" if it works in as little as three days.

A spokesperson for the Department of Consumer Protection told News 12 in a statement, "The Department of Consumer Protection is aware of the concerns and has continued to work with patients, prescribes, and pharmacies alike to ensure that patients have access to the medication they need to stay healthy. DCP is coordinating with sister agencies and the medical community to address potential supply issues of this important medication."